NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease
Journal:
Current Neuropharmacology
Volume:
10
Page:
272-285
Author(s):
Yu-Jhen Huang, Chieh-Hsin Lin, Hsien-Yuan Lane and Guochuan E. Tsaid
Neurocognitive Functioning and Cannabis Use in Schizophrenia
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4999-5007
Author(s):
Aviv Segev and Shaul Lev-Ran
Patient’s Perceptions of the Cannabis-psychosis Link - A Systematic Review
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
5105-5112
Author(s):
Anna Buadze, Stefan Kaiser, Rudolf Stohler, Wulf Roessler, Erich Seifritz and Michael Liebrenz
CNS Drug Development – Lost in Translation?
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
12
Page:
959-970
Author(s):
A. Talevi, C. L. Bellera, M. Di Ianni, M. Gantner, L. E. Bruno-Blanch and . A. Castro
Perspectives on the Development of Antioxidant Antiepileptogenic Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
12
Page:
1015-1027
Author(s):
J. Rowles and M. Olsen
Small Molecule-induced Beta-cell Regeneration from Alternate Cell Sources
Journal:
Current Tissue Engineering (Discontinued)
Volume:
1
Page:
83-90
Author(s):
Kai Hui Hu He, Tamara J. Gilbert, Dina Fomina-Yadlin and Bridget K. Wagner
Animal Models in Neurology: Drawbacks and Opportunities
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4443-4452
Author(s):
Robert Patejdl and Uwe K. Zettl
Neurodegeneration and Neuroprotection in Multiple Sclerosis
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4471-4474
Author(s):
Martin Stangel
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4570-4582
Author(s):
Alexander Winkelmann and Uwe K. Zettl
Recent Software Developments and Applications in Functional Imaging
Journal:
Current Pharmaceutical Biotechnology
Volume:
13
Page:
2166-2181
Author(s):
Lingfeng Wen, Stefan Eberl, Michael Fulham and (David) Dagan Feng